162 related articles for article (PubMed ID: 14983230)
1. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study.
Gatt ME; Paltiel O; Bursztyn M
Thromb Haemost; 2004 Mar; 91(3):538-43. PubMed ID: 14983230
[TBL] [Abstract][Full Text] [Related]
2. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J
Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362
[TBL] [Abstract][Full Text] [Related]
3. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.
Cushman M; Tsai AW; White RH; Heckbert SR; Rosamond WD; Enright P; Folsom AR
Am J Med; 2004 Jul; 117(1):19-25. PubMed ID: 15210384
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for venous thromboembolism in the elderly: results of the master registry.
Ageno W; Agnelli G; Imberti D; Moia M; Palareti G; Pistelli R; Rossi R; Verso M;
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):663-7. PubMed ID: 18832907
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.
Liperoti R; Pedone C; Lapane KL; Mor V; Bernabei R; Gambassi G
Arch Intern Med; 2005 Dec 12-26; 165(22):2677-82. PubMed ID: 16344428
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
[TBL] [Abstract][Full Text] [Related]
8. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
11. High incidence of venous thromboembolic events in lung transplant recipients.
Kahan ES; Petersen G; Gaughan JP; Criner GJ
J Heart Lung Transplant; 2007 Apr; 26(4):339-44. PubMed ID: 17403474
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis.
Gerber DE; Segal JB; Salhotra A; Olivi A; Grossman SA; Streiff MB
Cancer; 2007 Jan; 109(2):300-5. PubMed ID: 17154163
[TBL] [Abstract][Full Text] [Related]
13. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
[TBL] [Abstract][Full Text] [Related]
15. Racial and gender differences in the incidence of recurrent venous thromboembolism.
White RH; Dager WE; Zhou H; Murin S
Thromb Haemost; 2006 Sep; 96(3):267-73. PubMed ID: 16953266
[TBL] [Abstract][Full Text] [Related]
16. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.
Dentali F; Ageno W; Witt D; Malato A; Clark N; Garcia D; McCool K; Siragusa S; Dyke S; Crowther M;
Thromb Haemost; 2009 Sep; 102(3):501-4. PubMed ID: 19718470
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
18. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
19. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
20. Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission.
Aldington S; Pritchard A; Perrin K; James K; Wijesinghe M; Beasley R
Intern Med J; 2008 Feb; 38(2):133-5. PubMed ID: 18290829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
